Peptide profile
Afamelanotide
Also known as NDP-MSH
Melanocortin 1 receptor agonist
Approved medicines exist
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
Scenesse has a specific FDA-approved indication related to phototoxic reactions in adults with erythropoietic protoporphyria. Approval does not establish a cosmetic tanning indication.
View the supporting source- Research area
- Skin & tissue
- Biological target or mechanism
- Melanocortin 1 receptor agonist
- Evidence context
- Approved medicines exist
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
Explore the same area.
All skin & tissue profiles
Experimental peptide studied in tissue-repair signaling; target not established
Preclinical research
Read the profile 
Copper-binding tripeptide studied in extracellular matrix signaling
Preclinical research
Read the profile